| Title | Drug Design, Development and Therapy |
| Abbreviation | Drug Des. Dev. Ther. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1) |
| h-index | 94 |
| Overall Rank/Ranking | 4457 |
| SCImago Journal Rank (SJR) | 0.999 |
| Impact Score | 4.89 |
| Publisher | Dove Medical Press Ltd. |
| Country | New Zealand |
| ISSN | 11778881 |
| Best Quartile | Q1 |
| Coverage History | 2007-2023 |
Drug Design, Development and Therapy is a journal covering the technologies/fields/categories related to Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1). It is published by Dove Medical Press Ltd.. The overall rank of Drug Design, Development and Therapy is 4457. According to SCImago Journal Rank (SJR), this journal is ranked 0.999. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 94. The best quartile for this journal is Q1.
The ISSN of Drug Design, Development and Therapy journal is 11778881. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Drug Design, Development and Therapy is cited by a total of 5855 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Drug Design, Development and Therapy is 4.89, which is computed in 2024 as per its definition. Drug Design, Development and Therapy IF is increased by a factor of 0.06 and approximate percentage change is 1.24% when compared to preceding year 2022, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Drug Design, Development and Therapy is 4.89. If the same upward trend persists, Impact IF may rise in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 4.89 |
| 2022 | 4.83 |
| 2021 | 4.22 |
| 2020 | 3.89 |
| 2019 | 3.36 |
| 2018 | 3.22 |
| 2017 | 3.05 |
| 2016 | 3.04 |
| 2015 | 3.44 |
| 2014 | 3.52 |
Drug Design, Development and Therapy has an h-index of 94. It means 94 articles of this journal have more than 94 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Drug Design, Development and Therapy is 11778881. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Drug Design, Development and Therapy is 4457. According to SCImago Journal Rank (SJR), this journal is ranked 0.999. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.999 |
| 2022 | 0.887 |
| 2021 | 0.784 |
| 2020 | 0.964 |
| 2019 | 0.880 |
| 2018 | 0.986 |
| 2017 | 0.974 |
| 2016 | 0.993 |
| 2015 | 0.982 |
| 2014 | 1.034 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 4457 |
| 2022 | 5093 |
| 2021 | 5890 |
| 2020 | 4609 |
| 2019 | 5214 |
| 2018 | 4453 |
| 2017 | 4522 |
| 2016 | 4470 |
| 2015 | 4548 |
| 2014 | 4140 |
Drug Design, Development and Therapy is published by Dove Medical Press Ltd.. It's publishing house is located in New Zealand. Coverage history of this journal is as following: 2007-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Drug Design, Development and Therapy is Drug Des. Dev. Ther.. This abbreviation ('Drug Des. Dev. Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Drug Design, Development and Therapy latest impact IF is 4.89. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 4.89 (2023) and 3.04 (2016), respectively, in the last 10 years. Moreover, its average IS is 3.75 in the previous 10 years.
The Drug Design, Development and Therapy has an SJR (SCImago Journal Rank) of 0.999, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.034 in 2014 and the lowest being 0.784 in 2021. Furthermore, the average SJR of the Drug Design, Development and Therapy over the previous 10-year period stands at 3.75.
The latest h-index of the Drug Design, Development and Therapy is 94.
The Drug Design, Development and Therapy is published by the Dove Medical Press Ltd., with its country of publication being the New Zealand.
The Drug Design, Development and Therapy is currently ranked 4457 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 4140 in 2014 and its lowest position of 5890 in 2021.
The standard ISO4 abbreviation for the Drug Design, Development and Therapy is Drug Des. Dev. Ther..
Drug Design, Development and Therapy is classified as a journal that the Dove Medical Press Ltd. publishes.
The Drug Design, Development and Therapy encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Drug Design, Development and Therapy is assigned the following International Standard Serial Numbers (ISSN): 11778881.
The best quartile for the Drug Design, Development and Therapy is Q1 (2023).
The Drug Design, Development and Therapy coverage history can be summarized as follows: 2007-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Dermatologia Kliniczna | journal | 25442 | Cornetis | 7 | 0.00 |
| Tekstilec | trade journal | 18966 | University of Ljubljana Press | 15 | 0.91 |
| Acta Periodica Technologica | journal | 23723 | University of Novi Sad, Faculty of Technology | 21 | 0.31 |
| SPE International Formation Damage Control Symposium Proceedings | conference and proceedings | 21934 | 16 | 0.00 | |
| International Journal of Pest Management | journal | 13414 | Taylor and Francis Ltd. | 54 | 1.40 |
| International Journal of Press/Politics | journal | 711 | SAGE Publications Inc. | 81 | 7.76 |
| Brazilian Symposium of Computer Graphic and Image Processing | conference and proceedings | 16004 | 32 | 0.00 | |
| East African journal of public health | journal | 19634 | East African Public Health Association | 23 | 0.00 |
| Cuadernos de historia (Santiago, Chile) | journal | 19650 | Universidad de Chile | 5 | 0.17 |
| International Journal of Organizational Analysis | journal | 5983 | Emerald Group Publishing Ltd. | 41 | 5.28 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 4.89 |
| 2022 | 4.83 |
| 2021 | 4.22 |
| 2020 | 3.89 |
| 2019 | 3.36 |
| 2018 | 3.22 |
| 2017 | 3.05 |
| 2016 | 3.04 |
| 2015 | 3.44 |
| 2014 | 3.52 |
